CIK: 0001325083 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value ($000): $113,433 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Abeona Therapeutics Inc | 2,359,767 | $37,402 | 33.0% | $4.97 | — | COM | 00289Y107 |
| — | Corbus Pharmaceuticals HLDGS | 3,856,985 | $27,385 | 24.1% | $4.41 | — | COM | 21833P103 |
| — | Biohaven Pharmactl Hldg Co L | 807,224 | $21,779 | 19.2% | $25.00 | — | COM | G11196105 |
| — | Ampio Pharmaceuticals Inc. | 2,595,484 | $10,564 | 9.3% | $6.03 | — | COM | 03209T109 |
| — | Vascular Biogenics LTD | 896,771 | $6,367 | 5.6% | $4.71 | — | COM | M96883109 |
| KRYS | Krystal Biotech Inc | 300,000 | $3,156 | 2.8% | $10.08 | -0.6% | COM | 501147102 |
| AVXL | Anavex Life Sciences Corp | 724,205 | $2,332 | 2.1% | $3.56 | +10.5% | COM NEW | 032797300 |
| — | Soligenix Inc. | 870,000 | $1,835 | 1.6% | $2.11 | — | COM | 834223307 |
| VNRX | Volition RX LTD | 351,538 | $1,034 | 0.9% | $3.75 | -22.1% | COM | 928661107 |
| ALDX | Aldeyra Therapeutics Inc | 124,096 | $844 | 0.7% | $10.20 | -35.4% | COM | 01438T106 |
| — | Evoke Pharma Inc | 275,000 | $622 | 0.5% | $2.99 | — | COM | 30049G104 |
| — | Advaxis Inc. | 112,500 | $113 | 0.1% | $3.96 | — | W EXP 07/15/201 | 007624117 |